Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer
暂无分享,去创建一个
[1] J. Borlak,et al. N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients , 2006, BMC Medical Genetics.
[2] M. Doll,et al. Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. , 2001, Pharmacogenetics.
[3] D. Grant,et al. Update on consensus arylamine N-acetyltransferase gene nomenclature. , 2000, Pharmacogenetics.
[4] D. Hein. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. , 2000, Toxicology letters.
[5] U. Meyer,et al. Molecular mechanisms of genetic polymorphisms of drug metabolism. , 1997, Annual review of pharmacology and toxicology.
[6] J. Unadkat,et al. Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. , 1995, Biochemical pharmacology.
[7] A. Risch,et al. Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. , 1992, Pharmacogenetics.
[8] E. Sim,et al. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. , 1991, Biochemical pharmacology.